ANTI-TIF1-G POSITIVE DERMATOMYOSITIS WITH SEVERE OROPHARYNGEAL INVOLVEMENT AFTER IMMUNE CHECKPOINT INHIBITORS

被引：0

作者：

Tonutti, A. ^{[1
,2
]}

Luciano, N. ^{[3
]}

Ceribelli, A. ^{[1
,2
]}

Sonaglia, A. ^{[3
]}

Renna, D. ^{[3
]}

Repici, A. ^{[1
,4
]}

Lania, A. ^{[1
]}

Lleo, A. ^{[5
]}

De Nicola, S. ^{[6
]}

Bussini, L. ^{[7
]}

Morelli, P. ^{[7
]}

Pagani, M. ^{[8
]}

Selmi, C. ^{[1
,2
]}

De Santis, M. ^{[1
,2
]}

机构：

[1] IRCCS Humanitas Res Hosp, Milan, Italy

[2] Humanitas Univ, Rheumatol & Clin Immunol, Milan, Rozzano, Italy

[3] IRCCS Humanitas Res Hosp, Rheumatol & Clin Immunol, Milan, Rozzano, Italy

[4] Humanitas Univ, Gastroenterol & Digest Endoscopy, Milan, Rozzano, Italy

[5] Humanitas Univ, Liver Unit, Milan, Rozzano, Italy

[6] IRCCS Humanitas Res Hosp, Liver Unit, Milan, Rozzano, Italy

[7] IRCCS Humanitas Res Hosp, Infect Dis, Milan, Rozzano, Italy

[8] IRCCS Humanitas Res Hosp, Neuroctr, Neurorehabil Unit, Milan, Rozzano, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Myositis; Malignancy; Autoantibodies;

D O I：

10.1136/annrheumdis-2023-eular.3685

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0576

引用

页码：558 / 558

页数：1

共 50 条

[21] Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies
Muro, Yoshinao
Ishikawa, Asuka
Sugiura, Kazumitsu
Akiyama, Masashi
RHEUMATOLOGY, 2012, 51 (08) : 1508 - 1513
[22] Anti-TIF1-γ antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer
Li, J.
Yi, S.
Huang, Y.
Peng, Y.
Yang, Z.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 395 - 395
[23] Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based review
Jean-Baptiste Vulsteke
Petra De Haes
Minoru Satoh
Ben Van Cleynenbreugel
Benoit Beuselinck
Xavier Bossuyt
Ellen De Langhe
Rheumatology International, 45 (5)
[24] Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination
Yoshida, A.
Ikegami, T.
Igawa, K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : E517 - E520
[25] ANTI-TIF-1 G-ANTIBODIES IN JUVENILE DERMATOMYOSITIS ARE ASSOCIATED WITH VARIOUS CLINICAL PHENOTYPES
Bader-Meunier, Brigitte
Gitiaux, Cyril
Charuel, Jean-Luc
Fabien, Nicole
Melki, Isabelle
Quartier, Pierre
Belot, Alexandre
Streichenberger, Nathalie
Bodemer, Christine
Aussy, Audrey
Boyer, Olivier
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1933 - 1934
[26] NanoString technology distinguishes anti-TIF-1g+from anti-Mi-2+dermatomyositis patients
Preusse, C.
Eede, P.
Heinzerling, L.
Freitag, K.
Koll, R.
Froehlich, W.
Schneider, U.
Allenbach, Y.
Benveniste, O.
Schaenzer, A.
Goebel, H.
Stenzel, W.
Radke, J.
NEUROMUSCULAR DISORDERS, 2021, 31 : S52 - S52
[27] Paraneoplastic anti-TIF1-gamma-positive dermatomyositis as expression of cervical squamous cell carcinoma recurrence
van Erp, Mirthe A. J. M.
Slaats, Frank M. A.
Emmen, Judith M. A.
van Hamont, Dennis
BMJ CASE REPORTS, 2024, 17 (01)
[28] EFFECTIVE IMMUNOTHERAPY OF ANTI-TIF1-GAMMA-POSITIVE PARANEOPLASTIC DERMATOMYOSITIS WITH CONCURRENT DIAGNOSIS OF OVARIAN CANCER
Jazebi, Noushin
Shanina, Elena
MUSCLE & NERVE, 2019, 60 : S71 - S71
[29] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
Lerman, Irina
Richardson, Christopher T.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
[30] DRB1 is the primary genetic locus contributing to susceptibility to dermatomyositis positive for anti-TIF1γ antibody in Japanese
Yamaguchi, Y.
Kuwana, M.
Kanaoka, M.
Watanabe, T.
Okiyama, N.
Gono, T.
Kodera, M.
Kambara, T.
Hamaguchi, Y.
Seishima, M.
Takehara, K.
Fujimoto, M.
Aihara, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S89 - S89

← 1 2 3 4 5 →